Healthcare

Misuse of drugs like OxyContin is driving up the cost of insurance claims, and abuse of opioids is killing more people than cocaine and heroin combined.

Perhaps even more so than expanded coverage, the 2018 excise tax is driving plan change.

Industry insiders are beginning to find holes in the Affordable Care Act employer mandate delay announced last week by the Obama administration and U.S. Department of Treasury.

When you introduce the benchmarking dialog, you’re helping DC plan sponsors put a practical perspective on how their plans are doing today.

If plans aren’t drafted properly or if employees are improperly excluded, a qualification issue could result.

Sentiment offset by greater workloads, concerns over being replaced by lower-wage employees.

Auto-enrollment has been seen having great effect, but much more opportunity to help workers exists.

Starting next year, the health care reform act holds that a qualified individual cannot be denied coverage by a plan for related services from an approved clinical trial.

While the decision yesterday by the White House to delay this key provision in ACA was unexpected, what businesses is it really going to effect?

Benefits industry reacts to Obama administration's announcement of employer mandate delay until 2015.